万孚生物：公司持续响应社会对肝炎防治的健康需求

Core Viewpoint - Wanfu Bio has been dedicated to the in vitro diagnostic field for 30 years, responding to the health needs for hepatitis prevention and treatment by launching over 10 hepatitis detection products, covering various types of hepatitis and liver cancer [1] Group 1: Company Overview - Wanfu Bio has developed a comprehensive testing solution for hepatitis prevention and treatment, including products for hepatitis A, B, C, D, and liver cancer [1] - The company utilizes platforms such as colloidal gold, immunofluorescence, and chemiluminescence for its diagnostic products [1] Group 2: Industry Impact - The "Spark Plan" is being promoted in Guangdong and nationwide, aiming to enhance hepatitis screening and prevention efforts across a broader region [1] - The innovative outcomes from the "Spark Plan" are expected to provide strong support for hepatitis screening and prevention in more areas [1]